CYGNOS BIOTECH, LLC: federal contracts won
Federal contracts of $10,000 or more awarded to this company since October 2020 (FY2021), from USAspending.gov. UEI: PXYDY5CQJDM3
2contracts won
$1,601,657total obligated
$800,829median contract
Feb 02, 2026most recent start
Agencies it works for
| Agency | Contracts | Obligated |
|---|---|---|
| Department of Defense | 2 | $1,601,657 |
Industries (NAICS)
| NAICS | Contracts | Obligated |
|---|---|---|
| 541714 Research and Development in Biotechnology (except Nanobiotechnology) | 2 | $1,601,657 |
Where it works
Recent contracts
| Contract | Winner | Agency | Obligated | Start |
|---|---|---|---|---|
| THE PURPOSE OF THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE II CONTRACT IS TO SHOW EFFICACY OF ANTI-VIRAL TREATMENT WITH THE PVX THE…
W911SR26CA003 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Miami, FL |
— | Department of Defense Department of the Army |
$1,397,164 | Feb 02, 2026 Ends: Aug 01, 2027 |
| RESEARCH TO CREATE A CLASS OF AGNOSTIC DRUGS TARGETING THE HOST TO ASSIST IN FIGHTING OFF A BROAD SPECTRUM OF VIRAL PATHOGENS.
W911SR25C0013 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Miami, FL |
— | Department of Defense Department of the Army |
$204,493 | Mar 07, 2025 Ends: Sep 08, 2025 |
Source: USAspending.gov (prime contract awards of $10,000 or more). Values are amounts obligated to date. Recent months can still change as agencies report late.